ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0927

Improved Skin Lymphatic Flow Regulates Dendritic Cells to Mediate Lymph Node Fibroblast Alterations and Immune Responses in Lupus

Mir Howlader1 and Theresa Lu2, 1Weill Cornell Medical College, Brooklyn, NY, 2Hospital for Special Surgery, NEW YORK, NY

Meeting: ACR Convergence 2025

Keywords: innate immunity, Mouse Models, Lupus, skin, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus is a chronic autoimmune disease with a global loss of self-tolerance. Lupus patients are photosensitive where exposure to even ambient sunlight results in skin inflammation. Lymph carries signals such as antigens and antigen-presenting cells from the skin to the lymph node. We recently demonstrated that exposure to ultraviolet radiation (UVR) causes reduced lymph flow from skin to lymph node in lupus mouse models and that improving flow reduced B and T cell responses by increasing fibroblastic reticular cell (FRC) CCL2 expression and FRC proliferation (Howlader, Ambler et al. Journal of Clinical Investigation, vol. 135, no. 10, 2025, e168412). How improved flow can affect the lymph node stromal compartment is not understood. Migratory dendritic cells (DCs) travel in the lymph from skin to lymph node, where they can change FRC phenotype. Reduced interferon signaling results in increased FRC CCL2 expression and increased expansion of FRCs. Here, we hypothesize that improving lymph flow allows for more migratory DCs to mediate FRC proliferation through reduced interferon signaling.

Methods: We used an inducible lupus mouse model where topical imiquimod (a TLR7 agonist) induces a lupus-like phenotype with elevated type I IFN signaling. Mice were exposed to UVR 4 days/week to study photosensitivity. We improve flow through manual lymphatic drainage (MLD), which is a light skin stretching technique that helps promote the movement of lymphatic fluid out of a swollen area. To assess the role of DCs, we generated bone marrow chimeras using zDC-DTR donors into B6 recipients, enabling selective depletion of DCs via diphtheria toxin (DT). We analyzed LN immune and stromal populations by flow cytometry and quantified interferon stimulated gene (ISG) expression by qPCR.

Results: Improving lymph flow increased the number of migratory dendritic cells in the lymph node and not Langerhans cells or resident dendritic cells. Depletion of migratory dendritic cells prior to MLD reversed the FRC proliferation, indicating that migratory DCs are required for FRC proliferation. MLD led to reduced expression of lymph node ISGs and adding interferon reverses MLD induced FRC expansion. We currently are investigating if migratory dendritic cells are required for the reduced interferon signaling.

Conclusion: Our results support a potential DC-stromal axis that plays a role in lupus photosensitivity. Imporving lymphatic flow promotes migratory DC entry into LNs, which appears to suppress IFN signaling and promote FRC proliferation. These findings highlight a lymphatic-dendritic cell-stromal axis as a potential therapeutic target to alleviate photosensitivity-associated autoimmunity.


Disclosures: M. Howlader: None; T. Lu: None.

To cite this abstract in AMA style:

Howlader M, Lu T. Improved Skin Lymphatic Flow Regulates Dendritic Cells to Mediate Lymph Node Fibroblast Alterations and Immune Responses in Lupus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/improved-skin-lymphatic-flow-regulates-dendritic-cells-to-mediate-lymph-node-fibroblast-alterations-and-immune-responses-in-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improved-skin-lymphatic-flow-regulates-dendritic-cells-to-mediate-lymph-node-fibroblast-alterations-and-immune-responses-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology